Morepen Laboratories Dirección
Dirección controles de criterios 3/4
El CEO de Morepen Laboratories' es Sushil Suri , nombrado en Oct 2000, tiene una permanencia de 23.5 años. compensación anual total es ₹47.72M, compuesta por 91.8% salario y 8.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.31% de las acciones de la empresa, por valor de ₹347.49M. La antigüedad media del equipo directivo y de la junta directiva es de 7.3 años y 18.8 años, respectivamente.
Información clave
Sushil Suri
Chief Executive Officer (CEO)
₹47.7m
Compensación total
| Porcentaje del salario del CEO | 91.8% |
| Permanencia del CEO | 23.6yrs |
| Participación del CEO | 1.3% |
| Permanencia media de la dirección | 7.4yrs |
| Promedio de permanencia en la Junta Directiva | 18.9yrs |
Actualizaciones recientes de la dirección
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Recent updates
Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28Could The Morepen Laboratories Limited (NSE:MOREPENLAB) Ownership Structure Tell Us Something Useful?
Nov 09Can You Imagine How Morepen Laboratories' (NSE:MOREPENLAB) Shareholders Feel About The 75% Share Price Increase?
Oct 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Sep 17Morepen Laboratories Limited's (NSE:MOREPENLAB) Earnings Haven't Escaped The Attention Of Investors
Aug 26Is Now The Time To Put Morepen Laboratories (NSE:MOREPENLAB) On Your Watchlist?
Aug 19We Think Morepen Laboratories (NSE:MOREPENLAB) Can Stay On Top Of Its Debt
Jul 29Update: Morepen Laboratories (NSE:MOREPENLAB) Stock Gained 80% In The Last Five Years
Jul 08Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹761m |
| Sep 30 2023 | n/a | n/a | ₹531m |
| Jun 30 2023 | n/a | n/a | ₹477m |
| Mar 31 2023 | ₹48m | ₹44m | ₹387m |
| Dec 31 2022 | n/a | n/a | ₹428m |
| Sep 30 2022 | n/a | n/a | ₹553m |
| Jun 30 2022 | n/a | n/a | ₹768m |
| Mar 31 2022 | ₹91m | ₹87m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹54m | ₹51m | ₹971m |
| Dec 31 2020 | n/a | n/a | ₹814m |
| Sep 30 2020 | n/a | n/a | ₹684m |
| Jun 30 2020 | n/a | n/a | ₹453m |
| Mar 31 2020 | ₹17m | ₹16m | ₹336m |
| Dec 31 2019 | n/a | n/a | ₹331m |
| Sep 30 2019 | n/a | n/a | ₹312m |
| Jun 30 2019 | n/a | n/a | ₹340m |
| Mar 31 2019 | ₹12m | ₹11m | ₹288m |
| Dec 31 2018 | n/a | n/a | ₹252m |
| Sep 30 2018 | n/a | n/a | ₹267m |
| Jun 30 2018 | n/a | n/a | ₹308m |
| Mar 31 2018 | ₹6m | ₹4m | ₹296m |
Compensación vs. Mercado: La compensación total de Sushil($USD572.33K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD275.56K).
Compensación vs. Ingresos: La compensación de Sushil ha sido consistente con los resultados de la empresa en el último año.
CEO
Sushil Suri (59 yo)
23.6yrs
Permanencia
₹47,718,000
Compensación
Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 23.6yrs | ₹47.72m | 1.31% ₹ 314.2m | |
| Whole-Time Director | 9.3yrs | ₹18.12m | 1.08% ₹ 258.6m | |
| Chief Financial Officer | 9.8yrs | ₹9.80m | sin datos | |
| General Manager of Process Engineering & Technology Transfer | no data | sin datos | sin datos | |
| Manager of Administration | no data | sin datos | 0.62% ₹ 149.7m | |
| Company Secretary & Compliance Officer | 5.5yrs | ₹1.84m | sin datos | |
| Functional Head of Talent Acquisition & HRBP | less than a year | sin datos | sin datos | |
| Chief Operating Officer of API | less than a year | sin datos | sin datos | |
| Head of Medipath Division | no data | sin datos | 0.45% ₹ 107.0m | |
| Head of International Business Development | no data | sin datos | sin datos | |
| Chief Executive Officer of Consumer Division | no data | sin datos | 0.60% ₹ 143.1m | |
| Chief of R&D | no data | sin datos | sin datos |
7.4yrs
Permanencia media
46.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MOREPENLAB es experimentado (7.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 32.3yrs | ₹47.72m | 1.31% ₹ 314.2m | |
| Whole-Time Director | 4.8yrs | ₹18.12m | 1.08% ₹ 258.6m | |
| Independent Non Executive Director | 31.9yrs | ₹465.00k | sin datos | |
| Independent Non Executive Director | 18.9yrs | ₹575.00k | sin datos | |
| Independent Non Executive Director | 18.9yrs | ₹625.00k | sin datos | |
| Independent Director | 4.8yrs | ₹545.00k | sin datos | |
| Independent Director | 3.9yrs | ₹375.00k | sin datos |
18.9yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de MOREPENLAB son experimentados ( 18.8 años antigüedad media).